Centre of Excellence for Health, Immunity and Infections (CHIP), Rigshospitalet, Kobenhavn, Denmark
Centre of Excellence for Health, Immunity and Infections (CHIP), Rigshospitalet, Kobenhavn, Denmark.
BMJ Open. 2024 Nov 13;14(11):e089966. doi: 10.1136/bmjopen-2024-089966.
The Management of Post-transplant Infections in Collaborating Hospitals (MATCH) programme, initiated in 2011 and still ongoing, was created to 1) optimise the implementation of existing preventive strategies against viral infections in solid organ transplant (SOT) recipients and allogenic haematopoietic stem-cell transplant (HSCT) recipients and 2) advance research in the field of transplantation by collecting data from a multitude of sources.
All SOT and HSCT recipients at Copenhagen University Hospital, Rigshospitalet, are followed in MATCH. By February 2021, a total of 1192 HSCT recipients and 2039 SOT recipients have been included. Participants are followed life long. An automated electronic data capture system retrieves prospective data from nationwide registries. Data from the years prior to transplantation are also collected.
Data entries before and after transplantation include the following: biochemistry: 13 995 222 and 26 127 817; microbiology, cultures: 242 023 and 410 558; other microbiological analyses: 265 007 and 566 402; and pathology: 170 884 and 200 394. There are genomic data on 2431 transplant recipients, whole blood biobank samples from 1003 transplant recipients and faeces biobank samples from 207 HSCT recipients. Clinical data collected in MATCH have contributed to 50 scientific papers published in peer-reviewed journals and have demonstrated success in reducing cytomegalovirus disease in SOT recipients. The programme has established international collaborations with the Swiss Transplant Cohort Study and the lung transplant cohort at Toronto General Hospital.
Enrolment into MATCH is ongoing with no planned end date for enrolment or follow-up. MATCH will continue to provide high-quality data on transplant recipients and expand and strengthen international collaborations.
合作医院移植后感染管理(MATCH)项目于 2011 年启动,目前仍在进行中,旨在 1)优化实体器官移植(SOT)受者和异基因造血干细胞移植(HSCT)受者现有抗病毒感染预防策略的实施,2)通过从多种来源收集数据来推进移植领域的研究。
哥本哈根大学医院和里格绍尔医院的所有 SOT 和 HSCT 受者均纳入 MATCH 项目进行随访。截至 2021 年 2 月,共纳入 1192 名 HSCT 受者和 2039 名 SOT 受者。参与者将接受终身随访。一个自动化的电子数据采集系统从全国性登记处检索前瞻性数据。还收集了移植前的数据。
移植前后的数据输入包括以下内容:生化:13995222 次和 26127817 次;微生物学、培养物:242023 次和 410558 次;其他微生物分析:2650007 次和 566402 次;和病理学:170884 次和 200394 次。有 2431 名移植受者的基因组数据,1003 名移植受者的全血生物银行样本和 207 名 HSCT 受者的粪便生物银行样本。MATCH 收集的临床数据已为 50 篇同行评议期刊发表的科学论文做出贡献,并已成功降低 SOT 受者的巨细胞病毒疾病发生率。该项目已与瑞士移植队列研究和多伦多总医院的肺移植队列建立国际合作。
MATCH 的入组仍在进行中,没有计划的入组或随访结束日期。MATCH 将继续为移植受者提供高质量的数据,并扩大和加强国际合作。